Effects of D 3 K 2 With Periodontal Therapy in Diabetes Mellitus and Stage I‐II Periodontitis Patients
Oral Diseases · 2025
DOI: 10.1111/odi.15147 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Oral Diseases, 2025. Verfasst von Tolga Aydogan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Faculty of Dentistry, Kirikkale University, Kirikkale, Turkey. Hauptthemen laut MEDLINE: Periodontitis, Cholecalciferol. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Kırıkkale Üniversitesi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The aim of this study is to look into the clinical and biochemical outcomes of D 3 K 2 supplementation in addition to nonsurgical periodontal treatment (NSPT) for patients suffering from diabetes mellitus (DM) and periodontitis.
Methods
Thirty‐eight participants with DM and periodontitis were randomized into two different groups. The test group provided NSPT with D 3 K 2 whereas the control group received NSPT with placebo. Clinical periodontal parameters were recorded and serum and gingival crevicular fluid (GCF) were sampled at baseline and at the third and the sixth months after treatment. Glycated hemoglobin A1c (HbA1c), fasting blood glucose (FBG), 25(OH)D 3 , parathyroid hormone (PTH), calcium (Ca) and magnesium (Mg) values were determined in blood samples. GCF and serum interleukin (IL)‐1β and IL‐10 levels were analyzed using enzyme‐linked immunosorbent assay.
Results
All clinical periodontal parameters were importantly decreased at the third and sixth months after treatment compared to baseline in both groups. At the sixth month, 25(OH)D 3 levels in the test group were observed to be statistically significantly higher than in the control group ( p = 0.02). Serum IL‐1β showed a statistically significant decrease at the sixth month compared to baseline and the third month in control group.
Conclusion
According to this study, there is limited additional benefit of D 3 K 2 given with NSPT in individuals with DM and periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Faculty of Dentistry, Kirikkale University, Kirikkale, Turkey.
- Department of Periodontology, Faculty of Dentistry, Gazi University, Ankara, Turkey.
- Department of Internal Medicine, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey.
- Keskin State Hospital, Kirikkale, Turkey.
- Department of Biochemistry, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey.
ORCID-Profile: Meltem Karsiyaka Hendek
Förderung
- Kırıkkale Üniversitesi
Zitieren
APA
Aydogan, T., Karsiyaka Hendek, M., Unsal, B., Çifci, A., Varol, H., Kisa, U., & Olgun, E. (2025). Effects of D 3 K 2 With Periodontal Therapy in Diabetes Mellitus and Stage I‐II Periodontitis Patients. Oral Diseases. https://doi.org/10.1111/odi.15147
Vancouver
Aydogan T, Karsiyaka Hendek M, Unsal B, Çifci A, Varol H, Kisa U, et al. Effects of D 3 K 2 With Periodontal Therapy in Diabetes Mellitus and Stage I‐II Periodontitis Patients. Oral Diseases. 2025. doi:10.1111/odi.15147
BibTeX
@article{Aydogan2025,
author = {Aydogan, Tolga and Karsiyaka Hendek, Meltem and Unsal, Berrin and Çifci, Aydın and Varol, Hakan and Kisa, Uçler and Olgun, Ebru},
title = {Effects of D 3 K 2 With Periodontal Therapy in Diabetes Mellitus and Stage I‐II Periodontitis Patients},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15147}
}
EUVIMED